Effect of Standard vs Intensive Blood Pressure Control on the Risk of Recurrent Stroke: A Randomized Clinical Trial and Meta-analysis

JAMA Neurology

Volumn 76, Issue 11, 2019, Pages 1309-1318

  Kitagawa, Kazuo ^a   Yamamoto, Yasumasa ^b   Arima, Hisatomi ^c   Maeda, Toshiki ^c   Sunami, Norio ^d   Kanzawa, Takao ^e   Eguchi, Kazuo ^f   Kamiyama, Kenji ^g   Minematsu, Kazuo ^h   Ueda, Shinichiro ⁱ   Rakugi, Hiromi ^j   Ohya, Yusuke ⁱ   Kohro, Takahide ^k   Yonemoto, Koji ⁱ   Okada, Yasushi ^l   Higaki, Jitsuo ^m   Tanahashi, Norio ⁿ   Kimura, Genjiro ^o   Umemura, Satoshi ^p   Matsumoto, Masayasu ^q   Shimamoto, Kazuaki ^r   Ito, Sadayoshi ^s   Saruta, Takao ^t   Shimada, Kazuyuki ^u   more..

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b KYOTO KATSURA HOSPITAL   (Japan)

^c FUKUOKA UNIVERSITY   (Japan)

^d Fukuzumi Hospital   (Japan)

^e Mihara Mem Hosp   (Japan)

^f Department of Dental and Oral Surgery   (Japan)

^g Nakamura Memorial Hospital   (Japan)

^h NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

ⁱ UNIVERSITY OF THE RYUKYUS SCHOOL OF MEDICINE   (Japan)

^j OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^k JICHI MEDICAL UNIVERSITY   (Japan)

^l NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

^m Musculoskeletal Tumor Surgery Center   (Japan)

ⁿ SAITAMA MEDICAL UNIVERSITY INTERNATIONAL MEDICAL CENTER   (Japan)

^o Cardio renal and Health Research Institute   (Japan)

^p YOKOHAMA ROSAI HOSPITAL   (Japan)

^q Sakai City Medical Center   (Japan)

^r Japan Health Care College   (Japan)

^s TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^t KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^u Shin Oyama City Hospital   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE BESYLATE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIZZINESS; FAINTNESS; FEMALE; FOLLOW UP; HUMAN; HYPOTENSION; INTENSIVE CARE; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASM; MEDICAL HISTORY; META ANALYSIS; MULTICENTER STUDY; NUMBERS NEEDED TO TREAT; OPEN STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RISK; STANDARD; SYSTOLIC BLOOD PRESSURE;

EID: 85069894161     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2019.2167     Document Type: Article

References (19)

1. Feigin VL, Forouzanfar MH, Krishnamurthi R,; Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) and the GBD Stroke Experts Group. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010 [published correction appears in Lancet. 2014;383(9913):218.]. Lancet. 2014; 383 (9913): 245-254. doi: 10.1016/S0140-6736(13)61953-4 24449944
2. Staessen JA, Wang JG, Thijs L. Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet. 2001; 358 (9290): 1305-1315. doi: 10.1016/S0140-6736(01)06411-X 11684211
3. Gueyffier F, Boissel JP, Boutitie F,; INDANA (Individual Data Analysis of Antihypertensive Intervention Trials) Project Collabora tors. Effect of antihypertensive treatment in patients having already suffered from stroke: gathering the evidence. Stroke. 1997; 28 (12): 2557-2562. doi: 10.1161/01.STR.28.12.2557 9412649
4. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001; 358 (9287): 1033-1041. doi: 10.1016/S0140-6736(01)06178-5 11589932
5. Liu L, Wang Z, Gong L, Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature. Hypertens Res. 2009; 32 (11): 1032-1040. doi: 10.1038/hr.2009.139 19798097
6. Rashid P, Leonardi-Bee J, Bath P. Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke. 2003; 34 (11): 2741-2748. doi: 10.1161/01.STR.0000092488.40085.15 14576382
7. Katsanos AH, Filippatou A, Manios E, Blood pressure reduction and secondary stroke prevention: a systematic review and metaregression analysis of randomized clinical trials. Hypertension. 2017; 69 (1): 171-179. doi: 10.1161/HYPERTENSIONAHA.116.08485 27802419
8. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002; 360 (9349): 1903-1913. doi: 10.1016/S0140-6736(02)11911-8 12493255
9. Arima H, Chalmers J, Woodward M,; PROGRESS Collaborative Group. Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial. J Hypertens. 2006; 24 (6): 1201-1208. doi: 10.1097/01.hjh.0000226212.34055.86 16685221
10. Benavente OR, Coffey CS, Conwit R,; SPS3 Study Group. Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial. Lancet. 2013; 382 (9891): 507-515. doi: 10.1016/S0140-6736(13)60852-1 23726159
11. Wright JT Jr, Williamson JD, Whelton PK,; SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control [published correction appears at N Engl J Med. 2017;377(25):2506]. N Engl J Med. 2015; 373 (22): 2103-2116. 26551272
12. Zonneveld TP, Richard E, Vergouwen MD Blood pressure-lowering treatment for preventing recurrent stroke, major vascular events, and dementia in patients with a history of stroke or transient ischaemic attack. Cochrane Database Syst Rev. 2018; 7: CD007858. doi: 10.1002/14651858.CD007858.pub2 30024023
13. Mant J, McManus RJ, Roalfe A, Different systolic blood pressure targets for people with history of stroke or transient ischaemic attack: PAST-BP (Prevention After Stroke-Blood Pressure) randomised controlled trial. BMJ. 2016; 352: i708. doi: 10.1136/bmj.i708 26919870
14. Bath PM, Scutt P, Blackburn DJ,; PODCAST Trial Investigators. Intensive versus guideline blood pressure and lipid lowering in patients with previous stroke: main results from the pilot "Prevention of Decline in Cognition After Stroke Trial" (PODCAST) randomised controlled trial. PLoS One. 2017; 12 (1): e0164608. doi: 10.1371/journal.pone.0164608 28095412
15. Yusuf S, Diener HC, Sacco RL,; PRoFESS Study Group. Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med. 2008; 359 (12): 1225-1237. doi: 10.1056/NEJMoa0804593 18753639
16. Salam A, Atkins E, Sundström J,; Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of blood pressure lowering on cardiovascular events, in the context of regression to the mean: a systematic review of randomized trials. J Hypertens. 2019; 37 (1): 16-23. doi: 10.1097/HJH.0000000000001994 30499920
17. Zanchetti A, Liu L, Mancia G, Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial. J Hypertens. 2014; 32 (9): 1888-1897. doi: 10.1097/HJH.0000000000000254 24979303
18. Lawes CM, Rodgers A, Bennett DA,; Asia Pacific Cohort Studies Collaboration. Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens. 2003; 21 (4): 707-716. doi: 10.1097/00004872-200304000-00013 12658016
19. Shimamoto K, Ando K, Fujita T,; Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2014). Hypertens Res. 2014; 37 (4): 253-390. doi: 10.1038/hr.2014.20 24705419